Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2015 03:00 ET | Source: Pluri Inc.

Pluristem Awarded Grant From Israel's Ministry of Economy for Marketing Its PLX Cell Therapy in Japan

HAIFA, Israel, June 3, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced that it has been...
June 01, 2015 03:00 ET | Source: Pluri Inc.

Pluristem Granted Key Cell Patents in Asia, Russia, Mexico, and Israel

HAIFA, Israel, June 1, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced it has been granted...
May 27, 2015 03:30 ET | Source: Pluri Inc.

Pluristem to Present at the International Congress of Radiation Research and Chair Two Panels at the Annual Meeting of the International Society for Cellular Therapy

HAIFA, Israel, May 27, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced participation at...
May 25, 2015 05:07 ET | Source: Pluri Inc.

Pluristem Issues Letter to Shareholders

HAIFA, Israel, May 25, 2015 (GLOBE NEWSWIRE) -- Dear fellow stockholders, A common objective drives our efforts at Pluristem: to bring innovative, effective treatments to patients suffering from...
May 19, 2015 03:00 ET | Source: Pluri Inc.

Pluristem to Conduct Conference at Tel Aviv Stock Exchange to Review Regulatory Progress and Company Strategy

HAIFA, Israel, May 19, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced it will conduct a...
May 18, 2015 02:45 ET | Source: Pluri Inc.

Significant Progress for Pluristem: PLX Cells Were Selected for European Medicines Agency's Adaptive Pathways Pilot Project

HAIFA, Israel, May 18, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced a significant...
May 13, 2015 03:00 ET | Source: Pluri Inc.

Pluristem's PLX Cells One Step Closer to Entering Japan's Accelerated Pathway for Regenerative Medicine

HAIFA, Israel, May 13, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced that Japan's...
May 07, 2015 03:00 ET | Source: Pluri Inc.

Pluristem to Hold Symposium on Therapeutic Angiogenesis for Peripheral Arterial Occlusive Disease at European Society for Vascular Medicine in Berlin, Germany

HAIFA, Israel, May 7, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced that on May 12 it...
May 06, 2015 03:00 ET | Source: Pluri Inc.

Pluristem Granted European Patent for Use of Cells to Help Treat Damaged Bone Marrow

HAIFA, Israel, May 6, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, announced today that it has been...
May 04, 2015 03:00 ET | Source: Pluri Inc.

Pluristem to Present at Five Industry and Finance Conferences in May

HAIFA, Israel, May 4, 2015 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapy products, today announced that its executives...